A novel therapeutic approach for an existing drug reverses a condition in elderly patients who are at high risk for dementia due to Alzheimer’s disease, researchers at Johns Hopkins University found
The drug, commonly used to treat epilepsy, calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI), a clinically recognized condition in which memory impairment is greater than expected for a person’s age and which greatly increases risk for Alzheimer’s dementia, according to the study published this week in NeuroImage: Clinical.
The findings validate the Johns Hopkins team’s initial conclusions, published three years ago in the journal Neuron. They also closely match the results in animal studies performed by the team and scientists elsewhere. Next, neuroscientist Michela Gallagher, the lead investigator, hopes the therapy will be tested in a large-scale, longer-term clinical trial.
Hippocampal over-activity is well-documented in patients with aMCI and its occurrence predicts further cognitive decline and progression to Alzheimer’s dementia, Gallagher said.
“What we’ve shown is that very low doses of the atypical antiepileptic levetiracetam reduces this over-activity,” Gallagher said. “At the same time, it improves memory performance on a task that depends on the hippocampus.”
The team studied 84 subjects — 17 of them were normal healthy aged participants and the rest had the symptoms of pre-dementia memory loss defined as aMCI. Everyone was over 55 years old, with an average age of about 70.
The subjects were given varying doses of the drug and also a placebo in a double-blind randomized trial. Researchers found low doses both improved memory performance and normalized the over-activity detected by functional magnetic resonance imaging that measures brain activity during a memory task. The ideal dosing found in this clinical study matched earlier preclinical studies in animal models.
“What we want to discover now, is whether treatment over a longer time will prevent further cognitive decline and delay or stop progression to Alzheimer’s dementia,” Gallagher said.
Read more: Drug Restores Brain Function and Memory in Early Alzheimer’s Disease
The Latest on: Alzheimer’s Disease
[google_news title=”” keyword=”Alzheimer’s Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s Disease
- Signs of Alzheimer’s were everywhere. Then his brain improvedon May 17, 2024 at 11:01 pm
Preventive neurologist Dr Richard Isaacson stared at the numbers on the fax in astonishment. Blood biomarkers of telltale signs of early Alzheimer’s disease in the brain of his patient, 55-year-old ...
- ‘It took almost 5 years for my husband to be diagnosed with Alzheimer’s disease’on May 17, 2024 at 10:01 pm
Trish Davidson and her husband Howard were left frustrated by the time it took for his dementia to be diagnosed, despite doctors confirming he had mild cognitive impairment several years ago ...
- Researchers ID Unique Mutation Linked to Alzheimer's Disease Riskon May 17, 2024 at 11:17 am
Griswold: Dr. Cornejo-Olivas had identified a Peruvian family in which there were four Alzheimer's disease cases as well as two individuals with cognitive impairment. So that's six siblings, all with ...
- Black adults at risk for Alzheimer's disease live in more polluted areas, study findson May 17, 2024 at 11:01 am
"A lot of money has been spent on understanding the genetics and pathological characterization of Alzheimer's disease," said P. Murali Doraiswamy, MBBS, FRCP, a professor of psychiatry and behavioral ...
- Researcher discovers drug that may delay onset of Alzheimer's, Parkinson's disease and treat hydrocephaluson May 17, 2024 at 8:22 am
A researcher in the Keck School of Medicine of USC's department of surgery has discovered a potential breakthrough in delaying the onset of Alzheimer's and Parkinson's disease and treating ...
- The vicious cycle of protein clumping in Alzheimer's disease and normal agingon May 17, 2024 at 5:15 am
To date, approaches to treatments for Alzheimer's disease have not addressed the contribution of protein insolubility as a general phenomenon, instead focusing on one or two insoluble proteins.
- Dr Michael Mosley says four weeks of simple breathing trick can cut risk of Alzheimer's diseaseon May 17, 2024 at 12:41 am
A simple breathing technique which has been around for thousands of years could reduce the risk of Alzheimer's disease, according to Dr Michael Mosley. Speaking on his Just One Thing podcast on BBC, ...
- Can physical exercise help prevent Alzheimer's disease? Here's what to knowon May 16, 2024 at 2:01 am
In the next six years, 8.5 million Americans will have Alzheimer’s disease. New research shows how exercise can help the brain. Here's what to know.
- Treatment Trials in Alzheimer's Diseaseon May 15, 2024 at 9:00 pm
While $3.5 billion are spent annually in the U.S. on federally sponsored Alzheimer's research, only two disease-modifying treatments -- lecanemab (Leqembi) and aducanumab (Aduhelm, now discontinued) - ...
- Alzheimer's Newson May 15, 2024 at 5:00 pm
Research Sheds Light on How Proteins Linked to Alzheimer's Disease Influence Neuronal Growth May 15, 2024 — New research has shed light in the complex interplay between cell proteins ...
via Bing News